The use of intravesical hyaluronic acid in the management of symptomatic premenopausal women with pseudomembranous trigonitis: Are symptoms related to cystoscopy and pathological findings?

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:2996948 74 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
The use of intravesical hyaluronic acid in the management of symptomatic premenopausal women with pseudomembranous trigonitis: Are symptoms related to cystoscopy and pathological findings?
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Objectives: To determine the effectiveness and safety of intravesical hyaluronic acid (HA) in symptomatic women with trigonitis and to correlate the severity of symptoms with the endoscopic and histological findings. Methods: Thirty-seven patients (aged 20-46 years) were enrolled. All patients had cystoscopy and biopsy of the bladder trigone followed by intravesical instillations of sodium HA once weekly for 10 weeks and then once monthly for the next 10 months. Clinical response was evaluated by Pain and Urgency/Frequency (PUF) Symptom Scale, visual analog scale (VAS) for pain and urgency and functional bladder capacity. A repeat cystoscopy and biopsy were performed at the end of the treatment. Symptoms and cystoscopy and pathological findings were compared before and after treatment. Results: The average initial score for pain was reduced from 5.5 to 2.8 (P < 0.001) at 10 weeks and further to 2.4 (P < 0.001) at 12 months and the score for urgency from 6.9 to 3.8 (P < 0.001) and further to 3.3 (P < 0.001). The average PUF score initially decreased from 20.5 to 12.1 (P < 0.001) and then further to 10.1 (P = 0.21). The mean functional bladder capacity increased from 125 to 204 mL (P < 0.001). No association was found between baseline PUF score and cystoscopy findings (P = 0.87). The PUF score was not changed significantly between patients with improved cystoscopy and those with stable findings (P = 0.74). No significant changes were reported between initial and final biopsies. Conclusions: Intravesical HA appeared to be effective and well tolerated, although a clear relationship between symptoms and trigonitis was not confirmed. © 2021 John Wiley & Sons Australia, Ltd
Έτος δημοσίευσης:
2022
Συγγραφείς:
Stavropoulos, M.
Thakare, N.
Venieris, P.
Liakouras, C.
Deliveliotis, C.
Chrisofos, M.
Περιοδικό:
LUTS: Lower Urinary Tract Symptoms
Εκδότης:
John Wiley and Sons Inc
Τόμος:
14
Αριθμός / τεύχος:
1
Σελίδες:
57-63
Λέξεις-κλειδιά:
cystistat; hyaluronic acid; hyaluronic acid, adult; Article; bladder biopsy; bladder capacity; bladder disease; bladder trigone; clinical article; controlled study; cystoscopy; disease severity; drug efficacy; drug safety; drug tolerability; female; histopathology; human; human tissue; lower urinary tract symptom; maintenance therapy; Pain and Urgency Frequency Symptom Scale; pain assessment; patient care; premenopause; prospective study; pseudomembranous trigonitis; treatment duration; treatment response; urinary tract disease assessment; visual analog scale; cystitis; interstitial cystitis; intravesical drug administration, Administration, Intravesical; Cystitis; Cystitis, Interstitial; Cystoscopy; Female; Humans; Hyaluronic Acid
Επίσημο URL (Εκδότης):
DOI:
10.1111/luts.12410
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.